“Colistin efficacy for the treatment of severe infections caused by xdr acinetobacter baumannii in intensive care”, Univ. Med., vol. 57, no. 2, pp. 212–225, Jul. 2016, doi: 10.11144/Javeriana.umed57-2.ectp.